# PIK3AP1

## Overview
PIK3AP1, or phosphoinositide-3-kinase adaptor protein 1, is a gene that encodes the B-cell adaptor for PI3K (BCAP), a critical adaptor protein involved in the phosphoinositide 3-kinase (PI3K) signaling pathway. This protein plays a pivotal role in immune cell signaling by linking Toll-like receptors (TLRs) to PI3K activation, thereby modulating inflammatory responses and maintaining immune homeostasis. BCAP is characterized by structural domains such as the Toll/Interleukin-1 receptor (TIR) domain, which facilitates its function as a signaling adaptor. It is expressed in both lymphoid and myeloid cells and is involved in the regulation of cell proliferation, survival, and differentiation. The gene's expression and function are implicated in various diseases, including cancers and immune disorders, highlighting its clinical significance (Lovšin2020PIK3AP1; Guo2021Overexpression; Troutman2011Role).

## Structure
The PIK3AP1 protein, also known as BCAP (B-cell adaptor for PI3K), is characterized by several distinct structural domains that facilitate its role in signaling pathways. The protein contains a Toll/Interleukin-1 receptor (TIR) domain at the N-terminus, which is crucial for its function as a signaling adaptor linking Toll-like receptors (TLRs) to PI3K activation (Troutman2011Role; Troutman2012Tolllike). Following the TIR domain, BCAP includes a transcription factor-Ig (TIG) domain, a short conserved helical module, and a region with ankyrin repeats, which contribute to its structural stability and interaction capabilities (Troutman2012Tolllike).

BCAP exists in two isoforms, long (L) and short (S), which are generated through alternative splicing. These isoforms may have different roles or regulatory mechanisms in cellular signaling (Luff2021PI3Kδ). Post-translational modifications, such as tyrosine phosphorylation, are critical for BCAP's function, particularly in its interaction with PI3K components like p85, which is essential for TCR-induced signaling pathways in T cells (Luff2021PI3Kδ). The phosphorylation of BCAP is also necessary for recruiting PI3K upon TLR stimulation, highlighting its role in regulating inflammatory cytokine production (Troutman2012Tolllike).

## Function
PIK3AP1, also known as the B-cell adapter protein (BCAP), plays a crucial role in the PI3K signaling pathway, which is vital for regulating cell proliferation, survival, and metabolism. In healthy human cells, PIK3AP1 functions as an adaptor protein that links Toll-like receptors (TLRs) to the activation of PI3K, a family of serine/threonine kinases. This connection is essential for modulating the inflammatory response and maintaining immune homeostasis (Troutman2011Role; Troutman2012Tolllike).

BCAP is involved in the negative regulation of proinflammatory cytokine secretion upon TLR stimulation, thereby limiting excessive inflammatory responses. Its absence can lead to an exaggerated recruitment of inflammatory myeloid cells and increased susceptibility to inflammatory conditions such as colitis (Troutman2011Role). BCAP also plays a role in T-cell development into effector and memory cells and is expressed in both lymphoid and myeloid cell populations (Lovšin2020PIK3AP1).

In macrophages, BCAP acts as a signaling adaptor that dampens inflammasome activation, contributing to the regulation of systemic inflammation (Lovšin2020PIK3AP1). Through these mechanisms, PIK3AP1 is integral to the proper functioning of the immune system and cellular responses to external stimuli.

## Clinical Significance
Mutations and alterations in the expression of the PIK3AP1 gene have been implicated in various diseases. In cervical cancer, PIK3AP1 is highly expressed, and its expression is regulated by miR-142-5p. Overexpression of miR-142-5p suppresses PIK3AP1, leading to reduced cancer cell proliferation, migration, and invasion, suggesting a role in cancer progression (Guo2021Overexpression). In thyroid cancer, miR-1246 targets PIK3AP1, and its overexpression inhibits cancer cell proliferation and promotes apoptosis by affecting the PI3K/AKT signaling pathway (Li2021MiR1246). 

In gastric cancer, PIK3AP1 is part of a feedback loop with miR-567, influencing tumor growth and chemoresistance. High PIK3AP1 expression is associated with poor survival, and its regulation by miR-567 affects the PI3K/AKT-c-Myc pathway, crucial for cell proliferation and survival (Zhang2019A). 

A novel missense mutation in PIK3AP1 has been linked to familial cirrhosis, indicating a potential genetic predisposition to liver-related conditions (Abby2019A). Additionally, differential methylation of PIK3AP1 has been observed in PFAPA syndrome, suggesting a role in immune response regulation (Lovšin2020PIK3AP1). These findings highlight the clinical significance of PIK3AP1 in various diseases.

## Interactions
PIK3AP1, also known as the B-cell adapter protein (BCAP), is involved in several interactions within the phosphoinositide 3-kinase (PI3K) signaling pathway. It acts as a PI3K binding protein, playing a significant role in immune response regulation. PIK3AP1 interacts with the regulatory subunit of class I PI3K, known as p85, which is crucial for the activation of the PI3K/AKT signaling pathway. This interaction facilitates the downstream signaling processes that are essential for cell proliferation, survival, and differentiation (Liu2022BRG1).

In the context of immune cell signaling, PIK3AP1 is known to regulate inflammatory responses. It can inhibit proliferation and myeloid cell differentiation, functioning in a cell-intrinsic manner. This regulatory role is significant in T-cell development into effector and memory cells, and PIK3AP1 is expressed in both lymphoid and myeloid cell populations (Lovšin2020PIK3AP1).

PIK3AP1 also interacts with components of the B cell receptor signaling pathway, influencing immune response regulation. Its expression is modulated by methylation changes, which can affect its interaction with other signaling molecules and pathways, such as the PI3K-Akt signaling pathway (Zhang2020Abnormal).


## References


[1. (Lovšin2020PIK3AP1) Ema Lovšin, Jernej Kovač, Tine Tesovnik, Nataša Toplak, Daša Perko, Tomaž Rozmarič, Maruša Debeljak, and Tadej Avčin. Pik3ap1 and spon2 genes are differentially methylated in patients with periodic fever, aphthous stomatitis, pharyngitis, and adenitis (pfapa) syndrome. Frontiers in Immunology, July 2020. URL: http://dx.doi.org/10.3389/fimmu.2020.01322, doi:10.3389/fimmu.2020.01322. This article has 8 citations and is from a peer-reviewed journal.](https://doi.org/10.3389/fimmu.2020.01322)

[2. (Li2021MiR1246) Jingyan Li, Zhanlei Zhang, Jieting Hu, Xiaoting Wan, Wei Huang, Hong Zhang, and Ningyi Jiang. Mir-1246 regulates the pi3k/akt signaling pathway by targeting pik3ap1 and inhibits thyroid cancer cell proliferation and tumor growth. Molecular and Cellular Biochemistry, 477(3):649–661, December 2021. URL: http://dx.doi.org/10.1007/s11010-021-04290-3, doi:10.1007/s11010-021-04290-3. This article has 12 citations and is from a peer-reviewed journal.](https://doi.org/10.1007/s11010-021-04290-3)

[3. (Troutman2011Role) Ty Dale Troutman, Wei Hu, Stephanie Fulenchek, Tetsuo Yamazaki, Tomohiro Kurosaki, J. Fernando Bazan, and Chandrashekhar Pasare. Role for b-cell adapter for pi3k (bcap) as a signaling adapter linking toll-like receptors (tlrs) to serine/threonine kinases pi3k/akt. Proceedings of the National Academy of Sciences, 109(1):273–278, December 2011. URL: http://dx.doi.org/10.1073/pnas.1118579109, doi:10.1073/pnas.1118579109. This article has 143 citations.](https://doi.org/10.1073/pnas.1118579109)

[4. (Luff2021PI3Kδ) Daisy H. Luff, Katarzyna Wojdyla, David Oxley, Tamara Chessa, Kevin Hudson, Phillip T. Hawkins, Len R. Stephens, Simon T. Barry, and Klaus Okkenhaug. Pi3kδ forms distinct multiprotein complexes at the tcr signalosome in naïve and differentiated cd4+ t cells. Frontiers in Immunology, March 2021. URL: http://dx.doi.org/10.3389/fimmu.2021.631271, doi:10.3389/fimmu.2021.631271. This article has 14 citations and is from a peer-reviewed journal.](https://doi.org/10.3389/fimmu.2021.631271)

[5. (Guo2021Overexpression) Junliang Guo, Tian Tang, Jinhong Li, Yihong Yang, Yi Quan, Long Zhang, Wei Huang, and Muchuan Zhou. Overexpression of microrna 142-5p suppresses the progression of cervical cancer through targeting phosphoinositol-3-kinase adaptor protein 1 expression. Molecular and Cellular Biology, June 2021. URL: http://dx.doi.org/10.1128/MCB.00363-20, doi:10.1128/mcb.00363-20. This article has 10 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1128/MCB.00363-20)

[6. (Zhang2019A) Feifei Zhang, Kaitao Li, Xueqing Yao, Hui Wang, Weidong Li, Juan Wu, Mingyi Li, Rui Zhou, Lijun Xu, and Liang Zhao. A mir-567-pik3ap1-pi3k/akt-c-myc feedback loop regulates tumour growth and chemoresistance in gastric cancer. eBioMedicine, 44:311–321, June 2019. URL: http://dx.doi.org/10.1016/j.ebiom.2019.05.003, doi:10.1016/j.ebiom.2019.05.003. This article has 73 citations and is from a peer-reviewed journal.](https://doi.org/10.1016/j.ebiom.2019.05.003)

[7. (Troutman2012Tolllike) Ty Dale Troutman, J. Fernando Bazan, and Chandrashekhar Pasare. Toll-like receptors, signaling adapters and regulation of the pro-inflammatory response by pi3k. Cell Cycle, 11(19):3559–3567, August 2012. URL: http://dx.doi.org/10.4161/cc.21572, doi:10.4161/cc.21572. This article has 163 citations and is from a peer-reviewed journal.](https://doi.org/10.4161/cc.21572)

[8. (Abby2019A) Cyriac Abby Philips, Meenal Agarwal, Nikhil Phadke, Sasidharan Rajesh, Guruprasad Padsalgi, Rizwan Ahamed, and Philip Augustine. A novel phosphoinositide-3-kinase adapter protein 1 gene missense mutation in familial cirrhosis. Journal of Clinical and Experimental Hepatology, 9(5):652–656, September 2019. URL: http://dx.doi.org/10.1016/J.JCEH.2019.02.002, doi:10.1016/j.jceh.2019.02.002. This article has 1 citations.](https://doi.org/10.1016/J.JCEH.2019.02.002)

[9. (Liu2022BRG1) Gao Liu, Bao-Ye Sun, Jian Sun, Pei-Yun Zhou, Ruo-Yu Guan, Cheng Zhou, Zhang-Fu Yang, Zhu-Tao Wang, Jian Zhou, Jia Fan, Yong Yi, and Shuang-Jian Qiu. Brg1 regulates lipid metabolism in hepatocellular carcinoma through the pik3ap1/pi3k/akt pathway by mediating glmp expression. Digestive and Liver Disease, 54(5):692–700, May 2022. URL: http://dx.doi.org/10.1016/j.dld.2021.05.002, doi:10.1016/j.dld.2021.05.002. This article has 9 citations and is from a peer-reviewed journal.](https://doi.org/10.1016/j.dld.2021.05.002)

[10. (Zhang2020Abnormal) Andong Zhang, Shiying Yan, Mei Cao, Daoyan Wu, Jie Zhou, Zhihao Yu, Mengmeng Wu, Yi Liu, Shaofei Lu, Guoku Hu, and Jian Zhao. Abnormal methylation of pik3ap1 was involved in regulating the immune inflammatory response of ges-1 cells induced by helicobacter pylori. Biochemical and Biophysical Research Communications, 524(1):36–42, March 2020. URL: http://dx.doi.org/10.1016/j.bbrc.2020.01.007, doi:10.1016/j.bbrc.2020.01.007. This article has 8 citations and is from a peer-reviewed journal.](https://doi.org/10.1016/j.bbrc.2020.01.007)